J Korean Soc Endocrinol.  2002 Oct;17(5):720-729.

Diffuse nesidioblastosis underwent reoperation after streptozotocin treatment

Affiliations
  • 1Division of Endocrinology & Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine
  • 2Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea.
  • 3Department of Pathoogy, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea.
  • 4Department of Internal Medicine, Hallym University, College of Medicine, Korea.
  • 5Department of Pathology, Donga University, College of Medicine, Korea.

Abstract

Nesidioblatosis is a term that describes small clusters of pancreatic islet cells budding off exocrine ducts, and is commonly reported in infants with intractable idiopathic hypoglucemia. The onset of nesidioblastosis in adults is an extremely rare entity associated with hypersecretion of insulin and the treatment of choice is pancreatic resection. Medical treatment, including somatostatin, propranolol, diazoxide, hydrochlorthiazide and streptozotocin have achieved limited success. We experienced a case of adult nesidioblastosis that underwent reoperation after the failure of medical treatment following an inappropriate first operation. A 54-year old man was admitted due to intermittent hypoglycemic symptoms, which had been relieved by carbohydrate ingestion. Hyperinsulinemic hypoglycemia was documented during a prolonged fast. Image studies found no localized lesion, so a distal pancreatectomy was performed. The pathological examination of the resected pancreas revealed irregularly sized islets and a scattering of small endocrine cell clusters throughout the acinar tissue and ductuloinsular complex. After a partial pancreatectomy the hypoglycemia had not disappeared. The patient did not want to undergo a reoperaton due to the post operative wound infection that occurred after the distal pancreatectomy. Therefore, diazoxide, somatostatin, propranolol, and streptozotocin was used as the alternative to an operation. However, the hypoglycemia persisted during and after the medical treatment. Finally, he underwent a near total pancreatectomy (85%), and the hypoglycemia disappeared. The extent of pancreatectomy is important in clinical outcome of patients with nesidioblastosis


MeSH Terms

Adult
Diazoxide
Eating
Endocrine Cells
Humans
Hypoglycemia
Infant
Insulin
Islets of Langerhans
Middle Aged
Nesidioblastosis*
Pancreas
Pancreatectomy
Propranolol
Reoperation*
Somatostatin
Streptozocin*
Wound Infection
Diazoxide
Insulin
Propranolol
Somatostatin
Streptozocin
Full Text Links
  • JKSE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr